Takeshi Horio

14.3k total citations
308 papers, 10.0k citations indexed

About

Takeshi Horio is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Dermatology. According to data from OpenAlex, Takeshi Horio has authored 308 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Cardiology and Cardiovascular Medicine, 88 papers in Molecular Biology and 55 papers in Dermatology. Recurrent topics in Takeshi Horio's work include Neuropeptides and Animal Physiology (35 papers), Heart Failure Treatment and Management (34 papers) and Receptor Mechanisms and Signaling (32 papers). Takeshi Horio is often cited by papers focused on Neuropeptides and Animal Physiology (35 papers), Heart Failure Treatment and Management (34 papers) and Receptor Mechanisms and Signaling (32 papers). Takeshi Horio collaborates with scholars based in Japan, United States and Vietnam. Takeshi Horio's co-authors include Yuhei Kawano, Fumiki Yoshihara, Kenji Kangawa, Masakazu Kohno, Koji Yokokawa, Toshio Nishikimi, Hiroyuki Okamoto, Kiichiro Danno, Tadanao Takeda and Shuichi Takishita and has published in prestigious journals such as Nature, Circulation and The Journal of Immunology.

In The Last Decade

Takeshi Horio

302 papers receiving 9.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeshi Horio Japan 53 3.2k 2.9k 1.5k 1.4k 1.3k 308 10.0k
Raouf A. Khalil United States 62 2.4k 0.7× 3.2k 1.1× 2.3k 1.5× 381 0.3× 1.2k 0.9× 191 13.4k
Hidenori Koyama Japan 68 2.3k 0.7× 5.9k 2.0× 1.6k 1.0× 218 0.2× 1.3k 1.0× 414 15.1k
Masahiko Kurabayashi Japan 62 5.3k 1.7× 5.8k 2.0× 1.9k 1.3× 386 0.3× 2.0k 1.5× 572 16.9k
Kazuhisa Maeda Japan 42 2.9k 0.9× 4.3k 1.4× 5.5k 3.6× 552 0.4× 780 0.6× 133 16.0k
Amrita Ahluwalia United Kingdom 58 2.4k 0.7× 2.4k 0.8× 4.0k 2.6× 595 0.4× 831 0.6× 206 10.3k
Jan Nilsson Sweden 45 1.3k 0.4× 2.3k 0.8× 899 0.6× 899 0.7× 618 0.5× 102 7.6k
Wendy B. Bollag United States 51 533 0.2× 4.2k 1.4× 858 0.6× 363 0.3× 433 0.3× 287 8.7k
Barry L. Fanburg United States 48 1.7k 0.5× 4.5k 1.5× 2.2k 1.4× 522 0.4× 2.5k 1.9× 180 10.8k
Ákos Heinemann Austria 54 521 0.2× 1.8k 0.6× 1.8k 1.2× 689 0.5× 697 0.5× 214 7.2k
Ryoichi Takayanagi Japan 57 1.1k 0.3× 4.7k 1.6× 1.4k 0.9× 566 0.4× 853 0.7× 312 12.4k

Countries citing papers authored by Takeshi Horio

Since Specialization
Citations

This map shows the geographic impact of Takeshi Horio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Horio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Horio more than expected).

Fields of papers citing papers by Takeshi Horio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Horio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Horio. The network helps show where Takeshi Horio may publish in the future.

Co-authorship network of co-authors of Takeshi Horio

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Horio. A scholar is included among the top collaborators of Takeshi Horio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Horio. Takeshi Horio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwashima, Yoshio, et al.. (2023). Efficacy and safety of sacubitril/valsartan after switching from azilsartan in hemodialysis patients with hypertension. Journal of Clinical Hypertension. 25(3). 304–308. 6 indexed citations
2.
Doi, Yohei, Yoshio Iwashima, Fumiki Yoshihara, et al.. (2012). Renal Resistive Index and Cardiovascular and Renal Outcomes in Essential Hypertension. Hypertension. 60(3). 770–777. 91 indexed citations
3.
Nagai, Takashi, Keiya Inao, Atsushi Yokoyama, Takashi Iwafune, & Takeshi Horio. (2010). Probabilistic ecological risk assessment of eleven paddy herbicides. 20(4). 279–291. 7 indexed citations
4.
Ishimura, Kimihiko, Toshio Nishikimi, Takeshi Horio, et al.. (2009). OE-136 Prognostic Value of Combination of Adrenomedullin and Brain Natriuretic Peptide in Patients with Stable Cardiovasculer Disease(OE23,Heart Failure (Pathophysiology) (M),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society). Japanese Circulation Journal-english Edition. 73. 208–209. 8 indexed citations
5.
Ishihara, Satoru, Takeshi Horio, Yuso Kobara, Atsushi Yokoyama, & Shigeki Mayama. (2006). Development of A Growth Inhibition Test Method Using Fresh Water Attached Diatoms. 9(2). 101–113. 3 indexed citations
6.
Iwashima, Yoshio, Takeshi Horio, Yoshihiko Suzuki, et al.. (2005). Adiponectin and inflammatory markers in peripheral arterial occlusive disease. Atherosclerosis. 188(2). 384–390. 63 indexed citations
7.
Matsumura, Yasuhiro, Yasuhiro Matsumura, Yumi Matsumura, et al.. (2004). PIG7/LITAF gene mutation and overexpression of its gene product in extramammary Paget's disease. International Journal of Cancer. 111(2). 218–223. 17 indexed citations
8.
Ohe, Shuichi, Kiichiro Danno, Hiroko Sasaki, et al.. (2004). Treatment of acquired perforating dermatosis with narrowband ultraviolet B. Journal of the American Academy of Dermatology. 50(6). 892–894. 29 indexed citations
9.
Miyauchi‐Hashimoto, Hiroko, et al.. (2001). Carcinogen-Induced Inflammation and Immunosuppression Are Enhanced in Xeroderma Pigmentosum Group A Model Mice Associated with Hyperproduction of Prostaglandin E2. The Journal of Immunology. 166(9). 5782–5791. 19 indexed citations
10.
Horio, Takeshi, et al.. (2000). Evaluation of the Effects SK-P-9701 (Dextranomer paste) for the Treatment of Various Skin Ulcers. Skin research. 42(5). 514–527.
11.
Horio, Takeshi, et al.. (1997). The Action Mechanism of Phototherapy with Emphasis on Photoimmunologic Effects. Skin research. 39(3). 218–224. 1 indexed citations
12.
Hosokawa, Hiroshi, et al.. (1997). Two Cases of Episodic Angioedema with Eosinophilia. Skin research. 39(3). 252–255. 1 indexed citations
13.
Hashimoto, Hiroko, et al.. (1997). Papuloerythroderma (ofuji) Successfuly Treated with Oral PUVA Therapy: A Case Report. Skin research. 39(6). 579–582. 1 indexed citations
14.
Hashimoto, Hiroko, et al.. (1996). Cholinergic Urticaria Associated with Hypohidrosis. Skin research. 38(5). 505–510. 4 indexed citations
15.
Ikeda, Miwako, Masakazu Kohno, Takeshi Horio, et al.. (1995). EFFECT OF THROMBIN AND PDGF ON ENDOTHELIN PRODUCTION IN CULTURED MESANGIAL CELLS DERIVED FROM SPONTANEOUSLY HYPERTENSIVE RATS. Clinical and Experimental Pharmacology and Physiology. 22(s1). S197–8. 5 indexed citations
16.
Isei, Taiki, et al.. (1995). A case of apocrine adenocarcinoma of the axilla caused from apocrine adenoma.. Skin Cancer. 10(2). 156–159. 2 indexed citations
17.
Horio, Takeshi, et al.. (1993). Actinic Cheilitis: Report of a Case. Skin research. 35(3). 368–370.
18.
Nishijima, Setsuko, et al.. (1993). Photocontact Dermatitis and Contact Dermatitis from a Non-Steroidal Antiinflammatory Drug (Sector Lotion ®). Skin research. 35(1). 26–32. 2 indexed citations
19.
Isei, Taiki, Takeshi Horio, & Yasuo Asada. (1992). A Case of Malignant Lymphoma with Sweet's Syndrome-like Onset.. Skin research. 34(3). 333–340.
20.
Kohno, Masakazu, Koh‐ichi Murakawa, Takeshi Horio, et al.. (1990). Endothelin stimulates release of atrial natriuretic factor in anesthetized rats. Metabolism. 39(6). 557–559. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026